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OBJECTIVES: Describe the objectives of your study (maximum 30 words)
 
 
To compare the clinical, radiological and pathological 
characteristics of choledochal cysts in adults and children and 
describe differences if any.
 
 
METHODS:    Explain the clinical and statistical methods used (maximum 100 words)
 
 
All patients with choledochal cyst presenting to General Surgery 
IV, HPB Surgery and Pediatric surgery between November 2010 
and May 2012 were included.
-Informed consent was obtained from all participants.
-At laparotomy, bile was obtained from the common duct for 
measurement of Amylase and Lipase
-Intra-operative cholangiogram was performed thereafter.
-The presence of dysplastic changes and K-ras mutation in 
the epithelium was noted in the cyst at histopathological 
examination.
-Results were analysed to study the association between type 
of cyst/ junction and the junction length on one hand with the 
bile Amylase level/ pathological changes/ K-ras mutation in the 
lining epithelium on the other.
 
 
 
 
RESULTS:  Summarise the findings and conclusions of your study (maximum 90 words)
 
 
1. Choledochal cysts were commoner in females.
2. Common presenting complaints were pain, vomiting and 
cholangitis.
3. Coexisting pathology included gallstones, choledocholithiasis 
and biliary stricture.
4. The commonest cyst type was I in adults and IVA in children.
5. Ultrasonography and MRCP were the common diagnostic 
modalities used.
6. Long common channel was associated with higher serum/ bile 
amylase and lipase.
7. MRI and intra-op cholangiogram showed good correlation; 
MRI identified the common channel better.
8. Children showed higher bile amylase levels. 
9. K-ras mutation was uncommon (2/36).
10. Complications and positive bile cultures were commoner in 
adults.
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Introduction 
Choledochal cyst is a condition characterized by abnormal, aneurismal dilatation of a segment of 
the bile duct, usually in the extra-hepatic location.(1) Its incidence varies from 1 in 0.1-0.15 
million in the Western population to 1 in 1000 in Asia.(2) It is divided into 5 morphological types 
(2) of which types I and IVA are most common. 
Choledochal cysts are associated with abnormal junction of the pancreatic and common bile ducts 
outside the wall of the duodenum. This leads to the loss of the protective action of the sphincter of 
Oddi in the wall of the duodenum leading to reciprocal reflux of bile and pancreatic secretions. 
This predisposes to recurrent cholangitis, pancreatitis, stricture formation and choledocholithiasis 
secondary to stasis. Repetitive inflammation of the bile duct ultimately produces malignant 
transformation of the biliary epithelium secondary to several cycles of epithelial breakdown and 
repair.(3)  This theory is supported by the occurrence of several premalignant epithelial changes 
(dysplasia, biliary intra-epithelial neoplasia) as well as molecular changes (K-ras and p53 
mutations) in the cyst epithelium.(3) Complete excision of the cyst and hepatico-enterostomy is 
therefore recommended to disconnect the bile duct from the pancreatic duct and remove the 
diseased segment of the bile duct that could predispose to malignancy in the future.(4) 
This prospective study intended to compare the following features in adults and children presenting 
with choledochal cyst over an 18 month period to a tertiary care centre in South India:  
-Clinico-pathological profile, 
-findings on imaging, 
-operation performed and 
-post operative course. 
 
Aims of the study 
1. To classify patients who present with choledochal cyst into anatomical types as described 
by Todani.(5)  
 
2. To study the prevalence of pancreatico-biliary maljunction (PBM) in these patients, 
particularly with reference to the presence of long common channel (2).   
 
3. To compare magnetic resonance cholangiopancreatography (MRCP) with intra-operative 
cholangiogram (IOC) in the detection of cyst type and PBM. 
 
4. To study the association between PBM and elevated amylase level in the bile in the 
common bile duct. (6) 
 
5. To identify the presence of pathological changes in the bile duct associated with pancreatic 
reflux namely, hyperplasia, metaplasia, dysplasia and biliary intra-epithelial neoplasia (BilIN). 
 
6. To identify the presence of K-ras mutation in the epithelium of the cyst wall and factors 
that predict its occurrence. 
 
7. To correlate bile culture with post operative sepsis and to see if there is a relationship 
between the two. 
 
8. To describe differences (if any) between children and adults with respect to the above 
mentioned aspects of choledochal cyst.  
 
Review of literature 
Choledochal cyst is a defined as segmental, aneurismal dilatation of the bile duct, most commonly 
in its extrahepatic portion.(1) In such individuals, the diameter of the common bile duct exceeds 10 
mm.(3) Its incidence is varied and has been variously described as being as rare as 1 in 100,000 to 
150,000 in the Western population to being as common as 1 in 1000 in the Asian population for 
reasons that are not understood. (2) The frequency of various types of choledochal cyst in literature 
is: 
 50%–80% type I,  
2% type II,  
1.4%–4.5% type III,  
15%–35% type IV and  
20% type V.(2) 
The first classification system for choledochal cysts was proposed by Alonso Lej and colleagues in 
1959.(7) This system classified extrahepatic biliary dilatation into 3 types. Todani and colleagues 
incorporated intrahepatic biliary dilatation into this system to propose a modified classification that 
is widely accepted and used today.(5)  
Type I and IV are the commonest cyst types encountered. Type I cysts are subdivided into 3 
groups: IA- where there is dilatation of the entire extrahepatic bile duct, 
 IB- where the dilatation of the bile duct occurs distal to the cystic duct-common hepatic duct 
confluence and  
IC- where dilatation extends from the pancreatico-biliary junction to the intra-hepatic biliary tree. 
Recently, a ’ type ID’ cyst has been described in which the cystic duct is dilated in addition to the 
hepatic and common bile ducts giving it a bicornuate appearance.(1) 
Type II cysts are diverticuli that arise from the common bile duct while type III are those in which 
the intraduodenal portion of the common bile duct is dilated. Due to the similarity to ureterocoele, 
this variety has been christened as ‘choledochocoele.’  These have been further subdivided into 5 
types based on the relationship of the cyst to the pancreatic duct and ampulla of Vater.(8) Some 
authors have questioned the inclusion of choledochocoele as a type of choledochal cyst due to 
differences in clinical presentation, pancreatic duct anatomy and propensity to develop biliary tract 
cancers when compared with other types of choledochal cyst.(9) 
Type IV cysts are multiple and have been divided into 2 types: 
 IVA- where the dilatation involves both the extra hepatic as well as the intra hepatic bile ducts and   
IVB- where there are multiple dilated segments in the extra hepatic bile duct alone; the latter is 
seen as a ‘string of beads’ on imaging. 
Type V cysts exhibit cystic dilatation confined to multiple segments of the intrahepatic bile ducts. 
This type is also referred to as, ‘Caroli’s disease’ or ‘communicating cavernous ectasia.’ In these, 
the extrahepatic bile duct measures less than 3 cm in diameter.(10) 
Form fruste is a cyst type characterized by an abnormal junction of the common bile and 
pancreatic ducts with long common channel and distal common bile duct stenosis in the absence of 
biliary dilatation. Patients with this cyst type present with the classical symptoms of pain and 
jaundice.(11) 
Other cyst types that have been described include combination of type I and II cysts (diverticulum 
arising from type IC cyst)(12) and isolated cystic duct dilatation (‘type VI’ choledochal cyst).(13) 
 
 
Pathogenesis of choledochal cyst 
Several theories have been proposed to explain the development of choledochal cysts. These 
include the following: 
1. Babbitt’s theory: choledochal cysts are mostly associated with an abnormal junction of 
common bile duct and main pancreatic ducts; they unite outside the wall of the duodenum. This 
leads to mixing of pancreatic secretions and bile which causes activation of pancreatic enzymes 
and alters bile acids. Due to the higher pancreatic ductal pressures, there is reflux of these irritant 
contents into the common bile duct which leads to inflammation and weakening of the wall 
causing dilatation of the common bile duct.(14) Davenport and Basu contended that increased 
pressure in the common channel as opposed to that at the ampulla, contributed to pancreatico-
biliary reflux.(15) This theory has been corroborated by the finding that bile duct amylase levels 
are higher in patients with choledochal cyst than in controls.(16) Trypsin and Phospholipase A2 
levels were also found to be elevated in bile aspirated from choledochal cysts. Biliary epithelium 
which is dysplastic in PBM, secretes Enterokinase(17) which activates Trypsinogen to Trypsin 
which then activates Phospholipase A2. (18)This in turn contributes to the inflammatory 
breakdown and weakening of the bile duct wall. The higher the amylase level, the younger the age 
of onset of symptoms and greater the degree of epithelial dysplasia in the bile duct.(2) 
2. Another theory states that all choledochal cysts are a result of anomalous development of 
the bile duct secondary to increased epithelial proliferation in the cannulation period in biliary 
development. 
3. Davenport and Basu (15) suggested that choledochal cysts are analogous to Hirschsprung’s 
disease in pathogenesis. All neonatal choledochal cysts they studied were cystic and exhibited 
fewer ganglia as well as neurons in the wall. Aganglionosis possibly contributed to distal 
obstruction and proximal dilatation. 
4. The above theories do not explain the development of other cyst types such as II, III and V. 
Type II cysts are believed to be duplication cysts of the bile duct and type III cysts are believed to 
occur as a result of ampullary obstruction or sphincter of Oddi dysfunction.(2) Some authors 
believe that type III cysts are duplication cysts of either the distal bile duct or duodenum.(19) 
5. Type V cysts on the other hand, are believed to result from an arrest in duct plate modelling 
in hepatic development. In the 12
th
 week of intra-uterine life, the bile duct epithelial cells form a 
duct plate with two layers around the branches of the portal vein which, by selective resorption and 
remodelling, develops into the biliary tree. Large duct development arrest leads to the 
manifestation of Caroli’s disease while arrest at the ductule level contributes to intrahepatic cyst 
formation with fibrosis (Caroli’s syndrome). (2,20) 
Todani classification (5)
 
Other choledochal cyst types(2) 
 
 
Pancreatico-biliary maljunction 
Choledochal cysts are associated with PBM in 50-80 % of cases.(2) PBM is defined as the 
junction of bile and pancreatic ducts outside the wall of the duodenum, beyond the influence of 
the sphincter of Oddi.(21) However, this excludes abnormal junction due to acquired 
factors such as papillitis, common bile duct stones and neoplasms.(22)  The definition of PBM is 
not clear. The following definitions have been published so far: 
i) Common channel >15 mm.(24, 25) 
ii) Common channel >20 mm, perpendicular union of ducts/ both.(25) 
iii) Common channel 6 mm or more outside the duodenal wall.(26) 
iv) Common channel >15mm + bile amylase >10,000 U/L.(27) 
The prevalence of PBM is also varied and ranges from 1% in Europe(28), 0.9-1.5%(3) in Japan to 
8.7% in Taiwan(29) among patients who underwent ERCP for  complaints that could be attributed 
to biliary pathology. In India, Jesudason et al reported the incidence of PBM in choledochal cyst to 
be 14%.(30) 
PBM is not seen only in choledochal cyst. The presence of PBM in the absence of biliary dilatation 
has been documented in 22% of Japanese patients registered under the Japanese Study Group on 
pancreatico-biliary maljunction (JSPBM).(3)  
The theories that explain the development of PBM are also varied. According to one theory, there 
is an arrest in the migration of the junction into the wall of the duodenum which produces the 
characteristic morphology of a common channel. Another theory suggests that PBM is a result of 
misarrangement of the pancreatico-biliary duct system where the common bile duct joins the 
ventral branch of the pancreatic duct.(31) Komi et al proposed a system to classify PBM based on 
the angle of junction of the common bile duct with the main pancreatic duct: 
Type I- Junction at right angles.  
Type II- Junction at an acute angle.  
These are further classified as subtypes A- where the common channel is of normal calibre and B- 
where the common channel is dilated. 
Classification as type III is based on the configuration of the major and minor pancreatic ducts: 
Type III A: Both minor and major pancreatic ducts are patent and separate.  
Type IIIB: Minor duct patent, major duct absent distal to junction with common bile duct with no 
connection between the ducts.  
Type IIIC1- Patent minor duct, major duct distal to junction with common bile duct replaced by 
fibrous cord connecting with the minor duct. 
Type IIIC2- Both ducts patent, of normal calibre and communicating with each other. 
Type IIIC3- Both ducts patent, dilated and communicating with each other.  
The common channel may also be classified based on whether the common bile duct joins the 
pancreatic duct (c-p type) or vice versa (p-c type).(32) 
 
 
 
 
 
 
 
Classification of PBM(33) 
 
Long common channel 
The length of the common channel in PBM patients is usually greater than 1.87 cm.(3) Misra and 
Dwivedi defined the length of a long common channel to be greater than 8 mm.(34) However, Jona 
et al defined the long channel to be >10 mm in adults and >4mm in infants.(35) We should 
remember that there may be variations in the length of the common channel as a result of age, 
physical structure and radiological magnification used.(22) 
The problems associated with a long common channel are manifold: 
i) Carcinoma of the biliary tract, especially if >15 mm and even if >8 mm.(3,34) 
ii) Carcinoma pancreas.(3) 
ii) Choledochal dilatation of the bile duct.(34) 
iii) Pancreatitis, if the channel is long and its diameter greater than that of the stone.(34) 
 PBM has been associated with various pathological states such as choledochal cyst, gall bladder 
(GB) cancer, cholangiocarcinoma, GB adenomyomatosis, biliary pancreatitis, non biliary 
pancreatitis, hilar cholangiocarcinoma, cholelithiasis and pancreatic cancer.(36) 
In another study, it was observed that the incidence of K-ras mutation in cholangiocarcinoma is 
higher in those with long common channel. There is a sequential increase as one moved from 
proximal to distal extrahepatic bile duct. This suggests that long common channel has a bearing on 
biliary carcinogenesis possibly due to pancreatic reflux.(37) Factors that affect the degree of reflux 
include length and degree of dilatation of the common channel.(38) 
 
 
 
Biliary carcinoma 
It was believed that the frequency of gall bladder cancer is high in patients with PBM and normal 
calibre common bile duct while in those with choledochal cyst, cholangiocarcinoma 
predominates.(39) 
However, the JSPBM registry statistics in 2009 revealed that 12.9% of PBM patients with 
choledochal cyst exhibited biliary cancer (8.8% GB and 5.2% bile duct) while in those with a 
normal bile duct, the incidence was 38.5% (36.5% gallbladder and 4.0% bile duct). 
There was no difference between the incidences of cholangiocarcinoma in those with choledochal 
cyst when compared with those who had normal calibre bile ducts. When compared with the 
normal population in Japan, the incidence of bile duct cancer was 285 times higher in those with 
PBM.(3) Patients with PBM developed biliary cancers almost a decade earlier than the general 
population with a progressive increase in incidence with age.(40)   
From India, Misra and Dwivedi reported the incidence of gall bladder cancer in those with a long 
common channel to be as high as 67% (8 out of 12 patients).(34) In another study which compared 
biliary cancers in pediatric and adult patients with PBM it was found that there were no 
malignancies in the pediatric group. However, in adults, 13.3% of cystic type choledochal cysts 
demonstrated cholangiocarcinoma. GB cancer frequencies were as follows: cystic (6.7%), spindle-
like (33.3%) and non dilated (80.0%). Bile duct cancers were found to be more prevalent before 
the age of 40 years while the incidence of gall bladder cancers increased after that in patients with 
PBM associated with choledochal cyst.(40) This suggested the necessity for early excision of the 
common bile duct in those with choledochal cyst and cholecystectomy in those with normal calibre 
common bile duct, before the evolution of biliary carcinoma.(41) 
 
 
Pathogenesis of biliary cancer in PBM 
The precise mechanism of biliary carcinogenesis in PBM is not fully understood. Many events take 
place and could contribute to the development of biliary cancer.  
1. When the common bile duct and pancreatic duct unite outside the wall of the duodenum, 
the function of the sphincter of Oddi is lost. There is mutual regurgitation of bile and pancreatic    
secretions and stagnation in the GB and the dilated bile duct. 
2.  Pancreatic isoenzymes undergo activation when mixed with  Enterokinase secreted by the 
dysplastic biliary epithelium.(17)  
2. The action of Enterokinase on pancreatic isoamylases leads to the production of 
phospholipase A2 and lysolecithin which are cytotoxic.(34) 
4.   Bile acids are deconjugated leading to increased levels of secondary bile acids within the 
bile duct. Deoxycholic and cholic acid are structurally similar to Methylcholantrene which is a 
carcinogen.(3) 
5.  Pancreatic reflux is also believed to lead to lipid peroxidation and DNA oxidation in the 
biliary epithelium as evidenced by the presence of 4 hydroxy-2-nonenal-modified protein, a lipid 
peroxidation product and 8-hydroxy-2'-deoxyguanosine, an oxidative DNA base modified product 
in the gall bladders of patients with PBM.(42)   
 These changes result in epithelial injury and chronic inflammation within the bile duct. Repeated 
cycles of damage and repair of biliary epithelium leads to hyperplasia, metaplasia, dysplasia and 
carcinoma. This is brought about by DNA damage, mutation of tumour suppressor as well as 
oncogenes and acceleration of the cell cycle.(3) 
Analysis of the contents of the bile duct from patient s with PBM revealed mutagenicity in 50% by 
both the Ames as well as the spore rec test which respectively signify the mutagen’s ability to 
bring about frameshift mutations and DNA damage.(18, 43) These findings were echoed by Kato 
et al who used the Bacillus subtilis test to demonstrate mutagenicity.(44) The mutagens were 
thought to be amino acids with a molecular weight between 1500 and 3000.(18) Reciprocal reflux 
in PBM also predisposes to cholangitis, pancreatitis, bile duct stones and biliary carcinoma.(45) An 
interesting observation concerning reflux is that in patients with dorsal duct dominance (pancreas 
divisum), the bile amylase level and the incidence of gall bladder cancer was found to be lower. 
This was probably because of an alternative pathway of drainage of bile through the duct of 
Santorini as opposed to the main pancreatic duct of Wirsung and consequently, decreased reflux of 
pancreatic enzymes into the common bile duct from the main pancreatic duct.(46) (47) 
 
Histopathological changes 
The incidence and grade of epithelial hyperplasia is greater in the non cancerous epithelium of 
patients with PBM whether carcinoma gall bladder is present or not. (46, 47) Papillary hyperplasia 
is believed to be a precursor for gall bladder cancer and the risk was found to increase with 
age.(49) Epithelial hyperplasia (especially high grade) was more common in those with PBM and 
undilated bile duct than in those with a dilated duct. Non PBM epithelium was usually not 
associated with hyperplasia or dysplasia.(50) Direct correlation was observed between the degree 
of reflux (i.e., gall bladder amylase level) and the degree of epithelial hyperplasia in the gall 
bladder.(51) Hyperplasia and cell proliferation was especially more prevalent in the gall bladders 
of patients with P-C type of junction as compared to those with C-P type. This was attributed to 
greater likelihood of reflux and associated inflammatory changes in those with P-C type of 
PBM.(32) Reflux of pancreatic secretions into the bile duct in PBM is believed to lead to the 
sequence of chronic inflammation, hyperplasia, metaplasia, dysplasia and carcinoma (26).  Another 
observation was that larger the choledochal cyst, more intense the inflammation.(51) 
 
Molecular changes 
1) Proliferating cell nuclear antigen labelling index which used to measure cellular turnover, 
was higher in the non cancerous biliary epithelium of patients with PBM (irrespective of the duct 
diameter) in comparison with controls.(52)  
2) Ki-67, which is a marker for cellular kinetic activity, was found to be over-expressed in 
both cancerous as well as non-cancerous gall bladder epithelium in PBM (irrespective of duct 
diameter). The highest levels are found in gall bladder cancer associated with PBM and there was 
an association between Ki-67 over-expression and high grade epithelial dysplasia.(50)(45) 
3) Non neoplastic epithelium in PBM showed a high frequency of mucin core protein MUC1 
expression.  This was also observed in areas of dedifferentiation and invasion in the cancerous 
epithelium. This is suggestive of an altered cellular phenotype and increased potential for cancer in 
PBM.(53) 
4) Cyclo-oxygenase 2 (COX-2) and vascular endothelial growth factor (VEGF) are over-
expressed in the biliary epithelium of patients with PBM. These contribute to carcinogenesis by 
their anti-apoptotic and angiogenic actions respectively.(54) 
5)  Levels of 8 hydroxy 2 deoxyguanosine, which is a by product of oxidative DNA base 
modification, is higher in gallbladders of patients with PBM than in controls.  This shows that 
oxidative DNA damage occurs in PBM which may predispose to cancer.(42) 
 
Genetic changes 
1) Bcl 2, which is an inhibitor of apoptosis, was found to be expressed in the mitochondrial 
membrane of the cancerous as well as non-cancerous gall bladder epithelium in patients with PBM. 
However, it was not expressed in the cancerous or non-cancerous gall bladder epithelium in 
sporadic gall bladder cancer. Bcl 2 expression is probably an early event predisposing to biliary 
carcinogenesis in patients with PBM.(55) 
2) Telomerase activity, which predisposes to cancer, is increased in both cancerous as well as 
non-cancerous gall bladder epithelium in patients with PBM. However, it was not increased in 
non-cancerous gall bladder epithelium of sporadic gall bladder cancer.(55) 
3) Micosatellite instability (MSI) was found in 85.7% of hyperplastic lesions associated with 
PBM in Nagai’s study which shows that PBM may predispose to malignancy.(56) 
4) Inactivity of p53 leads to cell cycle dysregulation, impaired DNA repair and suppression of 
apoptosis. This in turn results in increased cellular proliferation that leads to malignant change. 
Various alterations including mutation, over-expression and loss of heterozygosity have been 
described with respect to p53.(3) P53 genetic alterations are believed to be a late event in biliary 
carcinogenesis and some authors have reported their occurrence only in carcinoma of the biliary 
tract.(56) Funabiki et al reported over-expression of p53 protein in 27.8% and 35.7% of gallbladder 
and bile duct epithelia of patients with PBM but without cancer. This frequency was 20% in the 
non-cancerous portion of the biliary tract in patients with PBM with biliary cancer and 57% in the 
cancerous portion.(3) Similarly, p53 mutations were found in 60% of gallbladder and 100% of bile 
duct cancers of patients with PBM. These figures were 45% and 64.3% respectively in those 
without PBM.(3) The frequency of loss of heterozygosity is very high in both cancerous as well as 
non cancerous epithelium of patients with PBM with gall bladder cancer.(3)  
5) P14-ARF mutations lead to loss of inhibition of p53-mdm2 interaction and subsequent 
dysfunction in p53 tumour suppression pathway. These mutations were frequent not only in the 
cancerous but also the non cancerous epithelium in PBM.(3) 
 
 
PBM and K-ras mutation 
K-ras mutations are common in the biliary epithelium of patients with PBM. They are chiefly in 
codon 12 of exon 1. The reports with respect to its incidence and association with biliary pathology 
from different investigators vary. (3) In one study K-ras mutations were found in hyperplastic, 
metaplastic and dysplastic epithelium of patients with PBM. No mutations were observed in the 
non cancerous epithelium of patients without dilated CBD. (57) Tomono et al reported the 
presence of K-ras mutation at codon 12 in not only bile duct/ gall bladder cancer associated with 
choledochal cyst, but also in epithelial atypia.(58) K-ras mutation was found only in those patients 
with PBM in a study on stage I gall bladder (33). The frequency of K-ras mutations in PBM related 
biliary pathology is higher than that in PBM unrelated pathology of the biliary tree. Hidaka et al 
demonstrated a higher incidence of K-ras mutation in patients with cholangiocarcinoma who also 
had a long common channel. There was a sequential increase in mutation frequency when one 
progressed from the proximal to the distal biliary tree; this supports the reflux theory of 
mutagenesis.(37) In another study, K-ras mutation was more prevalent in the gall bladders of 
patients without bile duct dilatation as compared to the bile ducts of patients with choledochal 
cyst.(39). A few investigators however, did not find any association between K-ras mutation and 
benign biliary tract lesions in patients without PBM. K-ras mutation is therefore, believed to be an 
early event in biliary carcinogenesis.(60, 61)  
 
 
 
Clinical features 
Most patients present before the age of 10 years. Two thirds present with two out of the classical 
triad of pain, jaundice and abdominal mass. While neonates present with jaundice and abdominal 
mass, older patients present with nausea, vomiting, pain, fever and jaundice.  These symptoms are 
attributable to reciprocal reflux and cholangitis/ pancreatitis. The dilated bile duct leads to bile 
stasis, protein plug precipitation, stone formation, inflammatory scarring and further obstruction. 
Pancreatitis could result from one of three causes- obstruction by stones, protein plugs or distal 
stricture. Protein plug formation occurs due to precipitation of protein rich inflammatory exudates 
or hypersecretion of mucin by dysplastic epithelium.  
Patients with intrahepatic stasis (type IC, IVA, V) present with recurrent cholangitis, intrahepatic 
abscess and ultimately, secondary biliary cirrhosis. This in turn leads to portal hypertension and 
even acalculous cholecystitis in some patients. 
Type 3 cysts may be asymptomatic or present with gastric outlet obstruction due to direct duodenal 
obstruction or intussusception.  
About 1-2% may present with biliary peritonitis secondary to rupture. Rupture is believed to occur 
because of inflammation induced mural fragility in combination with increased pressure within the 
duct or the abdomen.  
 
 
 
 
 
Diagnosis 
1. Ultrasonography 
The most commonly used imaging modality in the diagnosis of choledochal cyst is 
ultrasonography. All cyst types except III and V appear as cystic lesions at the porta which are in 
continuity with the bile duct. This differentiates them from pancreatic pseudocysts, hydatid cysts 
and biliary cystadenomas.(61) Ultrasonography is inexpensive, readily available in most instances, 
non-invasive and is non time consuming. There is no exposure to radiation involved. Its sensitivity 
has been reported to be 71-97% in literature.(62) However, ultrasonography is limited by body 
habitus, bowel gas, overlying structures and is operator dependant; it does not offer the anatomic 
detail that is obtained from MRI/ ERCP. Endoscopic ultrasound (EUS)overcomes many of these 
limitations and allows for visualization of the intrapancreatic bile duct.(63, 64) 
 
2. Magnetic resonance cholangiopancreatography (MRCP) 
This is now considered to be the gold standard in Hepatobiliary imaging. Bile and pancreatic 
secretions have different signal intensities as compared to the surrounding soft tissue which helps in 
image creation. However, blood, stones, protein plugs and air in the bile duct could interfere with 
image acquisition. Its sensitivity and specificity ranges from 90-100%.(64) However, MRCP is poor 
at imaging the pancreatico-biliary junction, tortuous ducts and stones/ ducts smaller than 5mm.(66, 
67) 
Administration of secretin prior to imaging may help by dilating the pancreatic duct due to 
increased pancreatic secretion.(67) MRI does not involve exposure to ionizing radiation, does not 
have complications of cholangitis/ pancreatitis, is operator independent and offers excellent 
anatomic detail. However, visualization of junction is poor and therapeutic procedures cannot be 
carried out. Gadoxetic acid enhanced functional MRI has recently been described as a tool to 
demonstrate reflux in pancreatico-biliary maljunction.(68)            
                                                                                                                  
3. Cholangiography 
Cholangiography involves visualization of the biliary tract after the injection of radio-opaque 
contrast into the biliary tree. This could be accomplished either via the ampulla at endoscopy 
(ERCP), the intrahepatic bile ducts percutaneously (PTC) or intra-operatively, most often through 
the cystic duct (IOC). It is useful in: 
1. Delineating biliary tract anatomy including that of the pancreatico-biliary junction before 
an operation. 
2.  Identification of filling defects (stones/ tumours).(69)  
3. In performing therapeutic procedures such as sphincterotomy and stone extraction. 
However, pitfalls include high risk of cholangitis and pancreatitis which increases with the contrast 
load used in large cysts.(67) 
Patients with choledochal cyst are at increased risk due to the presence of common channel, 
dysfunctional sphincter and dilated duct. Other problems include exposure to ionizing 
radiation(70), operator dependant results, little use in the post operative setting due to distal 
(intestinal) run off(71), technical difficulties in cases where the ampulla is scarred due to 
inflammation(70) and the need for anaesthesia in children(72). 
 
 
 
4. Computerized tomography (CT) 
CT is useful to study the intra-hepatic bile duct architecture, to demonstrate cyst continuity with 
the bile duct, identify malignant change within the cyst as well as study the distal common bile 
duct and pancreas.(73) Computed tomographic cholangiography could add further to anatomic 
detail obtained from CT. Virtual endoscopy of the bile duct and 3 dimensional reconstruction using 
cholangiography and spiral CT have also been used for this purpose and also in evaluating the 
anastomosis after the operation.(69) However, CT involves exposure to radiation and nephrotoxic 
contrast. 
 
5. Hepatobiliary Imino Diacetic Acid scan (HIDA scan) 
Technetium
99
 HIDA scan is primarily used to demonstrate bile duct continuity. This can 
differentiate biliary atresia from choledochal cyst in children by the absence of contrast entry into 
the small bowel in the former. HIDA can also identify cyst rupture and post op anastomotic leak by 
the entry of the isotope into the peritoneal cavity. However, anatomic detail, especially of the 
intrahepatic ducts is poor, which limits its sensitivity to 67% for type IVA cysts.(62) 
 
 
 
 
 
 
 
Treatment 
Treatment of choledochal cyst depends on the type of cyst and the clinical situation in which it is 
encountered. This has undergone several modifications in the last 80 years. In 1924, McWhorter 
described cyst excision followed by hepatico-jejunostomy.(74) However, this was not used for a 
long period of time due to several complications. Several other operations had been described 
including cyst marsupialisation, cystorraphy and cysto- enterostomy. These have been abandoned 
due to morbidity, mortality and the risk of malignant transformation in the future which is seen in 
as many as 30% of those who undergo internal drainage procedures.(75) 
Therefore, the standard of care today is excision of choledochal cyst from hepatic hilum to 
pancreatic duct with Roux-en-Y hepatico-enterostomy.(76) This separates the bile duct from the 
main pancreatic duct thereby preventing the reflux of pancreatic juice into the biliary tract and also 
removes the damaged portion of the bile duct with malignant potential.(4) If the cyst cannot be 
completely excised, the epithelium needs to be denuded or destroyed with alcohol or iodine.  
Hepatico-jejunostomy has a 92% success rate and a 7% complication rate as opposed to a 42% 
complication rate with hepatico-duodenostomy. The latter procedure carries with it the risk of bile 
reflux induced gastritis, esophagitis and hilar malignancy.(78, 79) However, there have been other 
reports to the contrary which make the choice unclear.(79) 
Various modifications of hepatico-enterostomy have been described. These include: 
1. End to end hepatico-jejunostomy. (No redundant jejunal pouch). 
2. Short Roux limb based on the distance between hepatic hilum and umbilicus. (Avoids 
complications of redundant jejunum). 
3. Wide stoma at hilum (3 cm or more) by extending incisions along the lateral walls of the 
hepatic duct. (Avoids anastomotic stricture). 
4. Appendiceal conduit between hepatic duct and jejunum. (Reduced cholangitis due to high 
follicle content in the appendix). 
5. Chicago-Beijing procedure (jejunal conduit between hepatic duct and duodenum with spur 
valve at duodenal anastomosis- reduced pancreatic reflux). 
6. Laparoscopic/ robotic hepatico-enterostomy (shorter hospital stay, comparable 
complication rate, decreased blood loss). 
7. Hepatico-cutaneous jejunostomy (dilatation of high intra hepatic strictures and stone 
extraction). 
Post operative complications following hepatico-enterostomy include bile leak, pancreatitis and 
bowel obstruction in the immediate post operative period. Late complications include anastomotic 
stricture, malignancy (0.7-6%), cholangitis, bile duct stones, pancreatitis and peptic ulcer. 
Intra-operative cholangioscopy may help in the removal of stones, protein plugs and debris which 
may prevent post operative biliary obstruction/ cholangitis. Also, the junction can be traced which 
may prevent inadvertent pancreatic duct injury during resection. Some authors have advocated pre-
operative biliary stent placement in patients who have symptomatic common bile duct stones.(80) 
Type II cysts could be removed by simple excision while type III cysts may be treated by ERCP 
and sphincterotomy if symptomatic as opposed to surgical resection of the intra-luminal portion of 
the cyst.(81) 
Type IV cysts call for hepatico-enterostomy with a wide hepatic stoma to facilitate bile 
drainage.(82) Following this, resolution of intrahepatic dilatation has been reported. Hepatico-
cutaneous jejunostomy (facilitates hepatic stone extraction/ lithotripsy) and segmental hepatectomy 
(focal dilatation with recurrent complications) may be indicated in some type IVA cysts.(83) 
Caroli’s disease is treated by hepatectomy if segmental or orthotopic liver transplantation if 
diffuse.(84) 
Form fruste cysts can be treated with either cholecystectomy alone or along with excision and 
hepatico-enterostomy as there are arguments that favour both procedures in literature.(84) 
Patients who present with biliary peritonitis following rupture are managed with emergent 
celiotomy, washout and external drainage of the perforation followed by definitive procedure at a 
second sitting. Rupture is commonly seen in pregnant women due to stasis secondary to biliary 
hypomotility as well as increased intra-abdominal pressure secondary to the gravid uterus and 
labour.(85) 
Coexistent malignancy mandates excision of the extra-hepatic bile duct, adjoining liver and the 
draining lymph nodes. However, less than 10 % of malignancies are resectable at presentation.(86) 
Finally, the definitive operative procedure is best performed in early neonatal period because 
beyond this, the incidence of hepatic fibrosis and post operative complications increases.(87) 
 
  
Materials and methodology 
-All patients with choledochal cyst presenting to General Surgery IV/ Department of HPB Surgery/ 
Department of Pediatric Surgery between Nov 2010 and May 2012 were included in the study. 
-As per institutional policy, children were defined as those less than 15 yrs of age and all those 
aged 15 years or more were included in the adult bracket. 
-Pre-operative evaluation of the biliary tree was carried out using ultrasonography and/ or MRCP 
with CT abdomen as per unit policy. 
-Informed consent was obtained from all adults and the assent form was administered to children 
(if appropriate) following which consent was obtained from the nearest relative present with the 
child before the operation.  
-At laparotomy, bile was aspirated from the common bile duct for measurement of amylase and 
lipase levels. 
-The bile amylase and lipase were measured under the supervision of a senior biochemist using a 
standardized colorimetric method using the substrate 4-nitrophenyl-maltoheptaoside.(88) 
-Intra-operative cholangiogram (IOC) was performed after the collection of bile sample. 
-IOC and MRCP images were reviewed by a senior radiologist and the cyst type and junction 
length were determined from them. 
-After excision, the proximal and distal ends of the excised cyst were labelled and subjected to 
histopathological examination. 
-The presence of the following changes in the cyst lining epithelium, were noted: epithelial 
hyperplasia, intestinal metaplasia, dysplasia and intra-epithelial neoplasia. The findings were 
verified by a senior HPB pathologist. 
-One slide with the above mentioned epithelial change(s) was selected for each patient and the area 
of interest was marked. 
- The corresponding block was subjected to tissue, DNA extraction and rt-PCR to detect the 
presence of K-ras mutation in codon 12. 
-Results were analysed to study the association between type of cyst/ junction and the junction 
length on one hand with the bile amylase and lipase level as well as pathological changes/ K-ras 
mutation in the lining epithelium on the other. The Chi square test was used in all instances to 
ascertain statistical significance except in the comparison of MRI and IOC, where correlation 
coefficient was employed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Results 
Age distribution (chart I) 
There were 17 children and 25 adults who were treated for choledochal cyst in the period between 
Nov 2010 and May 2012 in General Surgery IV/ Department of HPB Surgery / Department of 
Pediatric Surgery. All of these were elective admissions. 
 
Gender distribution (chart II) 
There was a female preponderance in both in both adults (18 out of 25) as well as children (14 out 
of 18). The female to male ratio among adults was 2.57:1 while among children it was 3.5:1 (0.67). 
 
Clinical presentation (chart III) 
The most common presenting features were pain (29%), jaundice (23%), vomiting (18%) and 
cholangitis (12%) in children. In adults, these were pain (96%), vomiting (48%) and jaundice/ 
cholangitis (20%). Children tended to present with jaundice more commonly than adults while pain 
was not as prominent a symptom in them. (90, 91). 
 
 
 
 Associated pathology 
Table 1 
 
 Adult Paediatric 
Bile duct stones 5 2 
Bile duct stricture 1 1 
Pancreatitis 1 2 
Gallstones 6 1 
Hepatolithiasis 1 0 
 
The common coexisting pathological conditions in adults and children treated for choledochal cyst 
is as shown in table no: 1. In addition to the above, biliary cirrhosis, portal hypertension, liver 
abscess and several developmental anomalies have been reported in literature. The developmental 
anomalies include atresia of the anus, duodenum and colon, pancreas divisum, pancreatic 
hypoplasia/ arteriovenous malformation, heterotopic pancreatic tissue, absence of portal vein, 
familial adenomatous polyposis (FAP), multiseptate gall bladder, ventricular septal defect, aortic 
hypoplasia and OMENS plus syndrome. (2) 
 
Serum bilirubin (chart IV) 
All patients were investigated with liver function tests and serum amylase/ lipase. Most patients 
had low serum total bilirubin level (<2 mg/dL). However, there was a greater fraction of children 
with high serum bilirubin than adults (p=0.2).(91) 
 
 Serum alkaline phosphatase (chart V) 
All children had elevated alkaline phosphatase values (>125 IU/L) while most adults had low 
alkaline phosphatase levels (p=0.03 for 300U/L cut-off). This could be explained by increased 
bone formation in children. 
 
Pre-operative imaging (chart VI) 
Ultrasonography and MRI were the commonest investigations used to diagnose choledochal cyst. 
While the former was more common in children, the latter predominated in adults. This reflects the 
changing trend of preferring MRI/ MRCP over ERCP in the diagnosis of biliary pathology. 
 
Serum amylase vs. channel length (chart VII) 
Among children, a greater number with a long common channel had a high serum amylase level 
(>100 IU/L) (p=0.76). However, among adults, the number with high serum amylase was equal to 
those with a low serum amylase, irrespective of the presence of a long common channel (p=1). 
Hyperamylasemia is seen in those with a common channel especially if > 10 mm in length due to 
the greater chance for pancreatico-biliary reflux.(92) 
 
Cyst type (chart VIII) 
While type I was the most common cyst type in adults, in children it was type IVA (p=0.33). In 
one child, the type of cyst could not be identified on imaging (IOC). 
  
Junction length and long common channel (chart IX) 
Junction lengths were divided into three groups based on length (34):  
- <8mm 
-8 and 15mm and  
->15 mm 
 Most adults had junction lengths that were either less than 8 or more than 15 mm. In case of 
children, most fell into the 8-15 mm bracket.  Twelve out of 25 adults and 5 out of 17 children had 
long common channel (>10 mm) (p=0.91).(3) 
 
Cyst type vs. junction length (chart X and XI) 
One view is that choledochal cysts are congenital in nature. Therefore, both the cyst and the 
common channel may be a result of the same developmental anomaly and the cyst type may 
correspond to the junction length.(93) There appears to be no difference in the prevalence of long 
common channel when type I cysts were compared with type IVA cysts in adults (p=0.55). In 
children, the long common channel was more prevalent in type I cysts (p=0.196). 
 
Junction length vs. bile amylase and lipase (charts XII and XIII) 
Among adults, a greater fraction of those with a short common channel had low bile amylase level 
(<200 IU/L) while the converse held true for those with a long common channel (p=0.12). Among 
children, the results were less clear with equal numbers in the low amylase level group (p=0.81). 
However, only those with a long common channel had amylase levels in excess of 50,000 IU/L. 
Thus, longer the channel length, the greater is the level of bile amylase which is in keeping with 
reports from literature.(38) A similar trend was observed when bile lipase levels were studied in 
relation to junction length. However, the results were less clear in children with equal numbers in 
the low and intermediate (10,000-50,000 IU/L) groups in those with a short common channel. 
However, the recurrent theme seemed to be that in those with a long common channel, there were a 
greater proportion of patients who had bile lipase levels in excess of 50,000 IU/L. 
 
MRI vs. intra-operative cholangiogram (chart XIV) 
There were 10 adults whose cyst types and junction lengths could be made out both on MRI and 
IOC. There was good correlation between MRI and intra-operative cholangiogram in identifying 
the junction length. There was no discrepancy in the type of cyst identified. (Correlation 
coefficient- 97.17). MRI is non invasive without exposure to radiation. It is a viable alternative to 
traditional imaging modalities in the study of biliary pathology. Intra-operative cholangiogram is 
user dependant and technically more demanding as compared to MRI. Moreover, it does not 
contribute to pre-operative planning and exposes both the patient and the surgical team to 
radiation. However, it is inexpensive as compared to MRI. 
 
Junction length on MRI and IOC (chart XV) 
The pancreatico-biliary junction and its length were better seen on MRI- in 81% of children and 
100% of adults. In IOC it was 16% of children and 47% of adults. This emphasizes the operator 
dependant nature of IOC. Therefore, although there was good correlation in the measurement of 
junction length between MRI and IOC, the former is better in identifying junction length and is 
therefore, the investigation of choice between the two. 
Bile amylase and lipase vs. age (chart XVI and XVII) 
The adult group showed an equal number of patients who had bile amylase level below 10,000 
IU/L and those with a level >10,000. In comparison, the pediatric group had a greater fraction in 
the >10,000 group (71%).  This was in keeping with the reports in literature that in those who were 
symptomatic and therefore, presented to the surgeon at a younger age, the bile amylase level was 
higher (p=0.89).(51)  Bile amylase level correlates with the symptoms and the degree of dysplasia 
in the bile duct.(2) A similar trend was observed when lipase levels in bile were compared with 
age. 
 
Bile culture (chart XVIII) 
Bile culture was obtained intra-operatively in most patients (14 out of 18 children and 25 out of 25 
adults). All the cultures (14) were sterile in children. Although most (13) adults had no growth on 
culture, 4 had monomicrobial and 7 had polymicrobial culture reports. However, there was no 
relationship between the presence of organisms in culture and the post operative course/ 
complication. 
 
Histopathology and K-ras mutation 
Chronic inflammation, hyperplasia, intestinal metaplasia and dysplasia were commonly observed. 
The first change was uniformly seen in all patients. Biliary intra-epithelial neoplasia was less 
common (2 patients).  There was no significant difference in pathological changes observed 
between adults and children. Similarly, there was no correlation of histopathology with bile 
amylase level/ cyst type/ channel length. K-ras mutation was observed in only two patients (1 adult 
and 1 child). This was probably because of low epithelial yield due to extensive denudation in the 
cysts and consequent non-representative samples.  
Operation performed (chart XIX) 
The commonest operation in adults was open hepatico-jejunostomy following excision of 
choledochal cyst. In children, the numbers were almost equally distributed between open hepatico-
jejunostomy and open hepatico-duodenostomy. One adult underwent radical cholecystectomy for 
carcinoma gall-bladder associated with choledochal cyst while in one child; laparoscopic hepatico-
duodenostomy was performed. 
 
Complications (chart XX) 
There were no post operative complications observed in children during the period of this study. 
However, complications were seen in 60% of the adults operated. The most common complication 
was bile leak (9 patients). One patient with bile leak required re-exploration, washout and trans-
anastomotic stent placement and another required pigtail drain placement for intra-abdominal 
collection.  The other 7 settled on conservative treatment.  The other complications include wound 
infection (2 patients), septicemia (1 patient), anastomotic leak requiring reoperation (1 patient), 
gastric distension (1 patient) and secondary hemorrhage (2- bleed into drain, 1- melena). Patients 
with secondary hemorrhage resolved without intervention. 
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VI) Pre-operative imaging 
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Picture 1 (Ultrasound) 
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Picture 6 (T-tube cholangiogram)                     
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IX) Pancreatico-biliary junction length 
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X) Long common channel 
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XIV) Comparison of MRCP with Intra-     
             operative cholangiogram (IOC) 
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XVI) Bile amylase level vs. age  
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XVII) Bile lipase level vs. age 
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XVIII) Bile culture in adults and children 
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Picture 7 (Epithelial hyperplasia, metaplasia) 
                   
 
 
Picture 8 (Biliary Intraepithelial Neoplasia- BilIN) 
 
 
 
 
 
 
 
 
 
Picture 9 (K-ras normal reverse sequence)
Picture 10 (K-ras reverse sequence: codon 13 GCC to ACC 
mutation) 
 
Picture 11 (K-ras reverse sequence: codon 12 ACC to AAC 
mutation)
 
Operation performed (chart XIX) 
 
HD: end to side Hepatico-duodenostomy (open) 
HJ: end to side Hepatico-jejunostomy (open) 
Other: Laparoscopic hepatico-duodenostomy (pediatric) - 1 
           Radical cholecystectomy + hepatico-jejunostomy (adult) – 1 
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Picture 12 (Intra-operative photograph) 
 
 
 
Type IA choledochal cyst with attached gall bladder as seen intra-operatively. 
 
  
Picture 13 (Intra-operative photograph) 
 
 
 
 
Another view of Type IA choledochal cyst with attached gall bladder as seen intra-operatively. 
 
 
 
 
 
Discussion 
Choledochal cysts were found to be more common in the female gender in both adults (18 out of 
25) as well as children (14 out of 18). The female to male ratio among adults was 2.57:1 while 
among children it was 3.5:1 which was in keeping with the reported ratio in literature (3:1 to 4:1). 
The most common presenting complaints were abdominal pain (96%), vomiting (48%) and 
jaundice/ cholangitis (20%) among adults.  Among children, these were: pain (78%), jaundice 
(61%) and vomiting (50%). Other presenting features included pancreatitis in 2 adults and 1 child 
and cyst rupture with peritonitis in 1 adult. No child had the classical triad of abdominal pain, 
jaundice and palpable mass. Jaundice was found to be a more common presenting symptom in the 
pediatric age group. Similarly, the remainder of the presenting symptoms were in keeping with 
reports in literature. These symptoms occur as a result of bile stasis and choledocholithiasis leading 
to cholangitis or main pancreatic duct obstruction secondary to stones/ protein plugs leading to 
pancreatitis.   
Associated pathology included choledocholithiasis (5 adults and 2 children), gall stones (6 adults 
and 1 child), pancreatitis (1 adult and 2 child), bile duct stricture (1 adult and child 
each) and hepatolithiasis (1 adult). PBM is known to be associated with choledochal cyst, gall 
bladder (GB) cancer, cholangiocarcinoma, GB adenomyomatosis, biliary pancreatitis, non biliary 
pancreatitis, hilar cholangiocarcinoma, cholelithiasis, choledocholithiasis and 
pancreatic cancer. The most common diagnostic modality used in the workup of these patients was 
ultrasound abdomen in children (97% of children and 56% of adults) and MRCP with CT abdomen 
in adults (88% adults and 78% children). ERCP was employed in 4 adults and 1 child; these 
patients presented with cholangitis. Twenty adults (80%) and 9 children (50%) underwent IOC as a 
part of this study. 
The commonest cyst type in adults was I (68%) followed by IVA (32%) while in children it was 
IVA (50%) followed by I (39%). Other types were not encountered in this study.  The reports in 
literature have described the prevalence of the various cyst types as follows: 50%–80% type I, 2% 
type II, 1.4%–4.5% type III, 15%–35% type IV and 20% type V. 
Long common channel (>10 mm) was seen in 13 out of 23 adults (56.5%) and 4 out of 8 children 
(50%).  Long common channel was encountered more often in children with type I (3 out of 4) as 
compared to type IVA cysts (2 out of 6). No such association was seen in adults.  The definition of 
PBM is not clear; a range from 1-4.5 cm has been described.  We have taken this as >1cm.  In 
literature, PBM is associated with choledochal cyst in 50-80% of cases and our results are in 
keeping with this. MRCP and IOC showed good correlation in detecting the cyst type and 
delineating the length of the common channel.  (Correlation coefficient- 97.17%). The cyst type 
was well demonstrated on MRCP [22 out of 22 adults (100%) and 11 out of 11 children (100%)] as 
well as IOC [16 out of 17 adults (94%) and 5 out of 6 children (83%)]. However, the common 
channel was more frequently seen on MRCP [22 out of 22 adults (100%) and 9 out of 11 children 
(81%)] than on IOC [8 out of 17 adults (47%) and 1 out of 6 children (16%)]. The sensitivity of 
MRCP for imaging choledochal cyst has been reported to be 90-100%; that for PBM has been 
reported to be between 46-60% and our results have shown a higher sensitivity.  However, intra-
operative cholangiography fared poorly in comparison with MRCP, possibly because of the 
operator dependant nature of the test and because of the fact that the anatomy of the cyst may 
obscure the junction (e.g. large cyst overlapping the junction, cyst with stones or terminal 
stricture). These disadvantages are often overcome in MRCP. 
Serum and bile amylase were higher in those with a long common channel.  In adults with channel 
length <10 mm, 3 out of 8 had a bile amylase >200 U/L while among those with >10 mm channel 
length, 8 out of 11 had a bile amylase level >200 U/L.  In children, 2 out of 3 with a short common 
channel had bile amylase level >200 U/L while 3 out of 4 with long common channel had a bile 
amylase level that exceeded 200 U/L.  
A greater fraction of children (5 out of 7, 71%) had higher bile amylase (>200 U/L) levels as 
compared to the adults (12 out of 20, 60%). This is in keeping with literature that suggests that bile 
amylase levels correlate with the degree of reflux and therefore the onset of symptoms; children 
present earlier due to higher amylase level in the common bile duct.  
Chronic inflammation was consistently seen on histopathology.  Hyperplasia (1 child, 4 adults), 
intestinal metaplasia (1 child, 3 adults) and biliary intraepithelial neoplasia {BilIN} (1 child and 
adult each), were less common.  
Many genetic changes suggestive of premalignant change have been reported in patients with 
PBM. These include: over-expression of Ki-67, mucin core protein 1, COX 2, vascular endothelial 
growth factor, bcl 2, 8 hydroxy 2 deoxyguanosine as well as mutations in tumour suppressor  genes 
such as p53 and K-ras. In this study, the cyst epithelium was studied for the presence of K-ras 
mutation. This was found in only two out of 36 samples while in literature, the prevalence has been 
described to be anywhere from 25% in non cancerous bile duct epithelium to 68.8% in 
cholangiocarcinoma. This may be attributed to low epithelial yield from cysts (most exhibited 
extensive epithelial denudation) and consequent inadequately representative samples. 
The most common operation performed was hepatico-jejunostomy in adults (24 out of 25) and 
children (10 out of 19). End to side hepatico-duodenostomy was a close second (8 out of 19) 
among children. Both these operations have been described for this condition in literature. 
Complications were more common in adults (15 out of 25) in the post operative period when 
compared with children (0 out of 18). The most common complication was bile leak (9 out of 15 
adults). Other complications included secondary haemorrhage (3/15), septicemia (1/15), wound 
infection (2/15), anastomotic leak requiring reoperation (1/15) and gastric distension (1/15). 
Bile cultures were positive in 12 out of 25 adults; culture was sterile in all the children (14 out of 
14).  Bile cultures were not predictive of the risk of post operative infective complications. 
The drawbacks of this study include:  
1. small sample size, 
2. heterogeneous adult population, 
3. different management protocols for adults and children, 
4. inability to visualize the common channel in some intra-operative cholangiograms and 
            MRCPs, 
5. short study period (18 months) making follow up incomplete and 
6. Very low prevalence of premalignant epithelial changes as well as K-ras mutation (2/42 
             samples).  
The last could be attributed to a low yield of epithelium from cysts as most exhibited extensive 
epithelial denudation.  Consequently, many samples may not have been adequately representative. 
  
Conclusions 
1. Choledochal cysts are more common in the female gender. 
2. The common presenting symptoms are upper abdominal pain, vomiting and jaundice/ 
cholangitis. 
3. Patients with choledochal cyst may exhibit such associated pathology as bile 
duct/gallbladder/ intrahepatic stones, pancreatitis and bile duct stricture. 
4. Children tend to have higher bile amylase level which is in keeping with reports from 
literature where those who were symptomatic at an early age, had higher bile amylase level.(51) 
5. The most common diagnostic modality used in these patients was ultrasonography 
followed by MRCP and intra-operative cholangiogram in that order. 
6. The most prevalent cyst types were type I in adults and type IVA in children. 
7. Long common channel was more prevalent in children with type I cysts when compared 
with those who had IVA cysts. 
8. Long common channel was associated with higher serum and bile duct amylase levels 
9. MRI and intra-operative cholangiogram exhibited good correlation in the study of the 
anatomy of the cyst and junction length.  
10. The percentage of junctions that could be identified and measured was greater for MRI 
(100% adults, 81% children) as compared with intra-operative cholangiogram (47% adults and 
16% children). This suggests that MRI is the imaging modality of choice in the study of 
pancreatico-biliary junction. 
11. The most common operation after cyst excision in adults was hepatico-jejunostomy while 
in case of children; the numbers were almost equally divided between end to side hepatico-
duodenostomy and hepatico-jejunostomy. 
12. Bile cultures tended to be sterile in children and polymicrobial in adults. There was no 
correlation between post- operative complications and bile culture results. 
13. Post operative complications were more frequent in adults as compared to children. 
14. The most common post operative complication was a spontaneously resolving bile leak. 
Other complications included wound infection, secondary haemorrhage, anastomotic leak requiring 
re-operation, gastric distension and septicemia, all of which were seen only in adults. 
15. Drawbacks of the study included small sample size, heterogeneous adult population, non-
uniform management protocols, inability to see the common channel in some images, incomplete 
follow up and low prevalence of K-ras mutation. 
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            Annexure 
                                    PROFORMA FOR DATA COLLECTION 
Name:                                               Age:                                       Sex: M/F 
Hospital no: 
Address: 
Phone no: 
Comorbid illness (please circle): Diabetes/ hypertension/ heart disease/   
      hypothyroidism/ asthma/ others (please specify). 
Complaints/ problems (please circle what is appropriate): 
1. Upper abdominal pain/ dyspepsia 
2. Fever >100F 
3. Obstructive jaundice 
4. Upper GI bleed 
5. Choledocholithiasis 
6. Pancreatitis 
7. Chronic liver disease 
8. Carcinoma gall bladder/ cholangiocarcinoma 
9. Incidental on imaging 
10. Other (please specify) 
Prior sphincterotomy: Y/N (if yes, please specify indication). 
Type of choledochal cyst: IA/IB/IC/II/III/IVA/IVB/V 
                                              (MRCP/ IOC/ both) 
Anomalous pancreaticobiliary junction (PBM): Present/ absent. 
Type of PBM: 1a/1b/2a/2b/3a/3b/3c1/3c2/3c3 
                           (MRCP/ IOC/ both) 
Common bile duct amylase level: <200/ 200-1000/ >1000 [value:          U/L] 
Serum amylase level                    : <200, 200-1000/>1000 [value;           U/L] 
Dysplasia in cyst epithelium: Absent/ present (type:                    ) 
Dysplasia in proximal duct   : Absent/ present (type:                    ) 
K-Ras mutation in cyst         : Absent/ present (codon 12/13, type:          ) 
K-Ras mutation in proximal duct: Present/ absent 
        (codon 12/13, type:              ) 
 
Operation: 
Findings: 
 
 Complications: Bile leak/ collection/ bleed/ septicaemia/ UTI/ LRI/ DVT/ wound  
Infection/ other (please specify) 
[Post op day of occurrence for each:      ] 
 
Outcome: Uneventful/ complication with recovery/ death 
 
Any other comments: 
 
PLEASE STICK THIS FORM IN THE LAST PAGE OF OUT PATIENT RECORD 
IN CASE OF ANY PROBLEMS, PLEASE CONTACT SUDHINDRA. J  
(9894411823)  
 
CONSENT FORM 
Name:                                     Age:                     Sex: M/F 
Hospital No:                            Date of operation: 
Name of operation: INTRA-OP CHOLANGIOGRAM, EXCISION CHOLEDOCHAL CYST 
WITH HEPATICOJEJUNOSTOMY/ HEPATICODUODENOSTOMY 
With regard to the operation: 
 I have been explained the indication, benefits and risks. 
 I have done this in terms and language which in my judgement are suited to the 
understanding of the patient/ responsible relative of the patient. 
 
 
Signature (with Employment number)    Name of doctor 
Date 
Patient/ Guardian: 
 I have been explained the nature of my illness, the need for and the type of operation for 
the same, its risks and the benefits. 
I agree: 
 To the proposed operation. 
 To the administration of general or local anaesthesia as deemed appropriate. 
 That any additional procedure if carried out will be in my best interests and justified for 
medical reasons. 
 To the transfusion of blood or blood products if needed. 
 To clinical photographs being taken and the use of fluid/ tissue from the operation for 
academic purposes to further medical knowledge. 
 
 
Name of patient                                            Signature (with date) 
Relationship (if not patient) 
 
 
 
 
 
 
 
 
 
                                                 PATIENT INFORMATION SHEET 
The bile duct connects the liver to the intestine and it is through this pathway that bile from the 
liver drains into the intestine. This duct is joined by a duct with similar function from the pancreas, 
in the wall of the intestine (food passage). There is usually a circular band of muscle around the 
end portion of these ducts which closes one to the other and prevents bile from entering pancreatic 
duct and vice versa. Choledochal cyst is dilatation of a portion of the bile duct. This condition is 
believed to increase risk of cancer of the bile duct and the gall bladder. This is probably because in 
these patients, the bile duct is joined to the pancreatic duct outside the wall of the intestine. This 
means that the action of the circular band of muscles is compromised and the contents of one duct 
mix with the other ie, reflux of pancreatic secretions occurs into the bile duct. Pancreatic secretions 
are rich in digestive juices that act directly on the bile duct and cause irritation and damage. This 
damage is repaired by the body. Over a prolonged period of time, this cycle of repeated damage 
followed by repair is believed to lead to cancer in a stepwise manner. Therefore, the current 
prescribed treatment for such patients is removal of the dilated portion of the bile duct and joining 
the remainder of the duct to a portion of the intestine. The following steps will be undertaken 
during the course of this operation: 
1) Cholangiogram (injection of a dye into the bile duct during the operation and a X ray of the 
abdomen. This delineates the ductal system). 
2) Aspiration of bile using a syringe and needle during the operation and testing for the level of 
amylase (a substance in pancreatic juice). We will anyway aspirate bile at the time of operation to 
look for microbes in the bile. 
3) Looking at changes in the removed cyst and a portion of the liver under a microscope and 
looking for the presence/ absence of an abnormal form of a gene called k-ras (gene: the portion of 
the cell that codes for its growth and multiplication). 
Complications of the operation include the following: 
1) Bile leak from the junction of bile duct and intestine. 
2) Bleeding during and after the procedure. 
3) Infection- within abdomen, of the chest/ wound/ urine/ blood. 
4) Possible need for reoperation/ radiological drainage procedure in case of 1). 
5) Pain/ scar on the abdomen. 
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Clinical audit  
Introduction 
Diabetes is a major public health problem in India and its prevalence continues to be on the 
rise. According to the Fourth Diabetes Atlas of the International Diabetes Federation (IDF), 
there were approximately 50.8 million cases in India in 2010 while by 2030; this is expected 
to be 87 million. It is estimated that the increase in the number of patients with diabetes in the 
developing world will thrice as much as that in the developed world.(1) Mohan et al 
estimated the prevalence of diabetes in South India to be 8.3% in 1989 which rose to 14.3% 
(72.3% increase, p<0.0001) by 2000. The age at diagnosis also showed a downward trend.(2) 
Misra et al observed the rate of increase of prevalence to be greater in males as compared to 
females in rural India.(3) By 2030, India, Pakistan and Bangladesh are expected to occupy 
three of the top ten slots in diabetes prevalence in the world. 
Patients with diabetes remain asymptomatic till they develop severe target organ damage 
(retinopathy, nephropathy, neuropathy, cardiovascular disease). Diabetes is the leading cause 
of blindness and kidney failure and the 6
th
 leading cause of mortality worldwide.(4) 
Therefore, effective screening and management strategies to combat this epidemic are the 
need of the hour. 
This study aimed to evaluate the completeness of evaluation of diabetes and 
recommendations offered to patients admitted in a General Surgery unit in a tertiary hospital 
in South India in the last year. 
Objectives 
To check if the following were included in the diagnostic workup of all patients with diabetes 
admitted in Surgery 4 between December 2011 and November 2012: 
1. HbA1c 
2. Fasting lipid profile 
3. Creatinine 
4. Either of UP/UC, urine microalbumin or 24 hr urine protein to assess proteinuria 
5. Documented examination of peripheral pulses 
6. ABPI with toe pressure 
7. Evaluation by Endocrinologist and counselling by diabetic educator 
 
To check if the following recommendations were included in the discharge summary of the 
above patients 
1. Lifestyle changes: diet, exercise and foot-care 
2. Low dose Aspirin 
3. Statin 
 
Materials and methodology 
 
This was a retrospective cohort study involving online survey of Surgery 4 discharge 
summaries (Dec 2011- Nov 2012) to identify patients with diabetes and study the above 
mentioned parameters. Results were analysed by Chi square test for significance. 
 
 
 
 
Inclusion criteria 
 
All patients admitted in Surgery 4 between Nov 2011 and Oct 2012 with the words 'Diabetes' 
or 'Diabetes mellitus' or 'Diabetic... (foot/abscess/ulcer etc)' in the diagnosis column of the 
discharge summary. 
 
Exclusion criteria 
 
1. Patients who died during treatment or were discharged against medical advice. 
2. Readmission in the same year (only first admission counted). 
3. Patients who have been advised diet regulation alone. 
4. Where the discharge summary does not mention the diabetic status of a patient. 
 
Criteria/ standards used 
 
The American Diabetes Association (5) and American Association of Clinical 
Endocrinologists (6) guidelines were used as a benchmark for data collection. The ideal rate 
of compliance was taken as 100%. 
 
Results 
 
1. Demographic profile 
There were a total of 212 patients who were included; 142 were male and 77 were female. 
 
                    
 
2. Age distribution 
Patients were classified as young (<60 yrs) or old (60 yrs or more). The young 
outnumbered the old among both males and females. (p=0.58). (Range 27-84 years). 
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3. Type of admission 
Admissions were classified as elective or emergency for further analysis. Emergency 
admissions were more common than elective. 
 
                       
 
4. HBA1c 
Glycated haemoglobin was measured in 86% patients. The respective percentages for 
elective and emergency admissions were 88 and 85%. (p=0.54). 
 
                       
 
5. Fasting lipid profile 
Fasting lipid profile was checked in 148 out of 212 patients (69.8%) of which 95 out were 
emergency and 53 were elective admissions.  In other words, lipid profile was checked in 
66.4% emergency and 76.8% elective admissions. (p=0.12). 
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6. Creatinine/ GFR 
This was measured in all patients, probably as a mandatory requirement for an operation. 
 
7. Evaluation of proteinuria 
Either of urine microalbumin/ urine protein to Creatinine ratio/ 24 hour urine protein was 
employed to evaluate proteinuria. This was done in 118 out of 212 admissions (55.7%). 
(p=0.19) 
 
                      
 
8. Palpation of peripheral pulses 
This was done in only 62 out of 212 admissions (29.2%). However, if only patients 
admitted for emergency operations on lower limbs were studied, this percentage was 
higher (58.6%) when compared with elective admissions (2.9%). (p= <0.000001). 
 
                       
9. ABPI measurement 
Measurement of the ankle-brachial pressure index with toe pressure was carried out in 38 
admissions (17.9%) out of which, the majority were in those undergoing emergency 
lower limb operations (37/ 38). (p=0.0001). 
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 10. Recommendations 
This included advice on diet, exercise, low dose Aspirin and statin. Diet advice was 
offered to 92.4% patients (94.4% emergency, 88.4% elective, p=0.12). The rates for 
Aspirin and statin were 29.9% (33.6 emergency, 20.2% elective, p=0.05) and 34.9% 
(38.5% emergency, 27.5% elective, p= 0.11) respectively. Most patients in our country 
are at increased risk for cardiovascular disease (4) and many have additional risk factors 
(50% in the present study) and would qualify for pharmacotherapy in addition to lifestyle 
modifications. 
 
                      
11. Education 
Evaluation by Endocrinologist and/ or counselling by certified diabetic educator during 
the course of inpatient admission were achieved in 48.11%. The rates for elective and 
emergency admissions were respectively, 18.8% and 62.2% (p <0000001). 
 
                      
 
Conclusions 
1. Most patients admitted to Surgery 4 in the last year were young males and the nature 
of admission was an emergency.  
2. Creatinine (100%), HBA1c (86%) and lipid profile (69.8%) was measured in a higher 
percentage of patients. 
3. Proteinuria (55.7%), palpation of pulses (29.8%) and ABPI measurement (17.9%) 
were less frequently carried out. 
4. Diet advice was given to most (92.4%) while diabetic education (48.11%), Aspirin 
(29.9%) and statin (34.9%) were given to a smaller fraction. 
5. Patients admitted for emergencies were on the whole; better evaluated and advised as 
compared to elective admissions (significant in case of pulse palpation, ABPI 
measurement, diabetic education and low dose Aspirin recommendation). This may 
be because they have greater end organ damage which comes to the attention of the 
treating physician and because patients with lower limb emergencies require 
evaluation of distal vascularity.  
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 Recommendations 
1. To manage all diabetic patients based on a protocol with a clinical checklist, in 
keeping with ADA/AACE guidelines. 
2. Better evaluation of peripheral pulses and ABPI, especially among those admitted for 
elective operations is required. 
3. Diabetic diet/ pharmacotherapy recommendations have to be studiously implemented 
in all patients. In the same vein, a plan for continuing review with Endocrinologist/ 
diabetic educator has to be made in consultation with the patient at discharge. 
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